Saw that. Seems like an unnecessary response in share price to the delay. That's a lot of patient data, requiring time to sift through it all. Maybe SRPT took up so much of their time, and now they need to get back to their logjam of work. :)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.